Show simple item record

FieldValueLanguage
dc.contributor.authorChen, X-Y
dc.contributor.authorWang, B
dc.contributor.authorYang, W
dc.contributor.authorKong, Fanrong
dc.contributor.authorLi, C-Y
dc.contributor.authorSun, Z-G
dc.contributor.authorJelfs, P
dc.contributor.authorGilbert, GL
dc.date.accessioned2015-01-28
dc.date.available2015-01-28
dc.date.issued2014-01-01
dc.identifier.citationChen X-Y, Wang B, Yang W, Kong F-R, Li C-Y, Sun Z-G, Jelfs P, Gilbert GL. Rolling circle amplification for direct detection of rpoB gene mutations in Mycobacterium tuberculosis directly from clinical specimens J Clin Microbiol. 2014;52:1540-48.en_AU
dc.identifier.urihttp://hdl.handle.net/2123/12653
dc.description.abstractRapid and accurate detection of multidrug resistance (MDR) inMycobacterium tuberculosisis essential to improve treatment outcomes and reduce global transmission but remains a challenge. Rifampin (RIF) resistance is a reliable marker of MDR tuberculosis (TB) since by far the majority of RIF-resistant strains are also isoniazid (INH) resistant. We have developed a rapid, sensitive, and specific method for detecting the most common mutations associated with RIF resistance, in the RIF resistance determining region (RRDR) ofrpoB, using a cocktail of six padlock probes and rolling circle amplification (RCA). We used this method to test 46 storedM. tuberculosisclinical isolates with known RIF susceptibility profiles (18 RIF resistant, 28 susceptible), a standard susceptible strain (H37Rv, ATCC 27294) and 78M. tuberculosisculture-positive clinical (sputum) samples, 59 of which grew RIF-resistant strains. All stored clinical isolates were correctly categorized, by the padlock probe/RCA method, as RIF susceptible or resistant; the sensitivity and specificity of the method, for direct detection of phenotypically RIF-resistantM. tuberculosisin clinical specimens, were 96.6 and 89.5%, respectively. This method is rapid, simple, and inexpensive and has the potential for high-throughput routine screening of clinical specimens for MDRM. tuberculosis, particularly in high prevalence settings with limited resources.en_AU
dc.description.sponsorshipa grant from The National S&T Major Special Project on Major New Drug Innovation (2012ZX09301002-005-003) from the Ministry of Science and Technology of Chinaen_AU
dc.language.isoenen_AU
dc.publisherAmerican Society for Microbiologyen_AU
dc.titleRolling circle amplification for direct detection of rpoB gene mutations in Mycobacterium tuberculosis directly from clinical specimensen_AU
dc.typeArticleen_AU
dc.type.pubtypePublisher's versionen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.